Faculty
Oncology Division
Ravi Vij, MD, MBA
Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia
Research Interests
- Stem cell transplantation for hematologic malignancy
- Multiple myeloma
- Acute myeloid leukemia/myelodysplastic syndromes
Contact
- 314-454-8304 (office)
- 314-454-7551 (fax)
- rvij@wustl.edu
- Division of Oncology
Mail Stop 8007-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - 11th Floor Mid Campus Center (office)
Biosketch
| Education | |
|---|---|
| 1989 | MBBS, Maulana Azad Medical College, University of Delhi, New Delhi, India |
| 2012-2013 | Healthcare MBA, George Washington University |
| Post-graduate Training | |
| 1990 | Rotating Internship, Lok Nayak Jayaprakash Narayan & G.B. Pant Hospitals, New Delhi, India |
| 1992-1993 | Senior House Officer, Halifax General Hospital and Royal Infirmary, Halifax, West Yorkshire, UK |
| 1993-1996 | Residency, Internal Medicine, Rush Presbyterian St. Luke's Medical Center, Chicago, IL |
| 1996-1999 | Fellowship, Medical Oncology/Hematology, Washington University, St. Louis, MO |
| 1999-2000 | Fellowship, Bone Marrow Transplantation//Malignant Hematology/Stem Cell Biology, Washington University, St. Louis, MO |
| Academic Positions | |
| 2000-2004 | Instructor of Medicine, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO |
| 2001-2004 | Staff Physician, Section of Hematology/Oncology, John Cochran VA Medical Center, St. Louis, MO |
| 2004-2007 | Assistant Professor of Medicine, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO |
| 2007-2015 | Associate Professor of Medicine, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO |
| 2015-present | Professor of Medicine, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO |
| 2016-present | Medical Director, Siteman Cancer Center, Barnes West County Hospital, Barnes St. Peter's Hospital, South County Satellite |
| Board Certification | |
| 1996, 2006 | Internal medicine |
| 1999, 2008 | Oncology |
| 2000, 2010 | Hematology |
| Honors & Awards | |
| 1998 | AACR/ASCO Clinical Cancer Research Scholar |
| 1999 | Amgen Fellows Scholarship |
| 2005-2014 | Listed in Best Doctors in America (Best Doctors, Inc.) |
| 2007 | Teacher of the year (Hematology/Oncology Fellowship Program) |
| 2008 | Honoree, Multiple Myeloma Laugh for Life (MMRF) |
| 2008 | Honoree, CUREiosity (Siteman Cancer Center Charity Gala) |
| 2010 | Honoree, BJC Foundation Cancer Frontier Fund Charity Gala |
| 2011 | Chair, Race for Multiple Myeloma |
| 2011 | Multiple Myeloma Research Consortium Center of Excellence Award |
| 2013 | Multiple Myeloma Reasearch Foundation Innovator Award |
| 2017 | Multiple Myeloma Reasearch Foundation Collaborator Award |
| Professional Societies | |
| American Society of Clinical Oncology | |
| American Society of Hematology | |
| American Society of Bone Marrow Transplantation | |
| Extramural Committees | |
| 2006-2010 | NCCN Anemia Guidelines Committee |
| 2006-present | CALGB Core Transplant Committee |
| 2011-present | CALGB Myeloma Committee |
| 2011-present | CALGB Leukemia Committee |
| 2011-present | Multiple Myeloma Research Consortium (MMRC) Steering Committee |
| 2013-present | CTN Myeloma Committee |
| 2014-2015 | Scholar Selection Committee (Alliance for Clinical Trials in Oncology Foundation) |
| 2015- 2018 | ASCO Education Committee |
| 2016-2019 | ASH Scientific Committee on Plasma Cell Neoplasia |
| 2022-present | ASCO Scientific Committee |
| Intramural Committees | |
| 2002-2004 | Performance Improvement Committee, John Cochran VA Medical Center |
| 2002-2005 | Protocol Review and Monitoring Committee, Siteman Cancer Center |
| 2004-2005 | Transfusion Committee, Barnes-Jewish Hospital |
| 2007-present | Washington University Hematology-Oncology Fellowship Committee |
| 2013-present | Washington University Heme-Onc Fellowship Clinical Competency Committee |
| 2014-present | K12 Paul Calabresi Career Development Awards Program Review Committee |
| 2015-present | Siteman Investment Program Study Section |
| 2017-present | BJH High Cost Medication Committee |
| Other Responsibilities | |
| 2005-2006 | MDS Treatment Resource Center, NMCR |
| 2008-present | Safety Oversight Group, Carfilzomib-003 Study (Proteolix) |
| 2009-2011 | DSMB, VANTAGE 88 and 95 Trials (Merck) |
| 2012-2014 | DSMB, Phase 2/3 Study of Tabalumab + Bortezomib and Dexamethasone (Eli Lilly) |
| Steering Committee, PREAMBLE Study (Bristol Meyer Squibb) | |
| Steering Committee, COMPASS Study (MMRF) | |
| 2014-present | Multiple Myeloma Steering Committee: Medscape |
| 2016, 2021 | ICER report on Myeloma: Faculty Advisor |
